Xeris Biopharma Holdings Inc (NASDAQ:XERS) traded at $4.20 at last check on current trade day and made a downward move of -0.83% on its previous day’s price. Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 57.87M, with
Xeris Biopharma Holdings Inc (NASDAQ:XERS) shares, rose in value, with the stock price up by 17.37% to the previous day’s close as strong demand from buyers drove the stock to $4.43. Actively observing the price movement in the recent trading, the stock is buoying the
Xeris Biopharma Holdings Inc (NASDAQ:XERS) price on Thursday, February 06, fall -1.36% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $3.62. A look at the stock’s price movement, the close in the last trading session was $3.67,
Xeris Biopharma Holdings Inc (NASDAQ:XERS) price closed lower on Friday, January 31, and dropping -2.73% below its previous close. A look at the daily price movement shows that the last close reads $3.66, with intraday deals fluctuated between $3.47 and $3.72. The company’s 5Y monthly
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
